Connect with us

Emerging Markets

Mexico uses human trials as path to secure future Covid-19 vaccines

Published

on


Mexico has agreed to host human trials of seven Covid-19 vaccines to strengthen relations with pharmaceutical companies in case limited production capacity leads to a battle for doses.

“We are saving places in the queue for the purchase of something that does not yet exist,” said Martha Delgado, a deputy foreign minister, who has led Mexico’s efforts to secure vaccines. “You cannot wait to see it before getting in line . . . there is a risk some countries will say ‘this is all for me’,” she told the Financial Times in an interview.

Mexico’s willingness to host phase 3 trials reflects wider concerns among many middle- and lower-income countries that they could struggle to secure sufficient vaccine doses once a Covid-19 shot is finally approved for use.

Dealmaking by the US, UK, EU, Japan and other rich nations has meant wealthy countries representing just 13 per cent of the world’s population have already bought more than half of the leading vaccine candidates’ promised doses, according to Oxfam.

To keep up, countries such as Mexico have had to adopt other strategies. Latin America’s largest economy will host vaccine trials for US companies Johnson & Johnson and Novavax, China’s CanSino, Russia’s Gamaleya Institute, Germany’s CureVac, France’s Sanofi Pasteur and Italy’s ReiThera.

“Mexico has been abnormally aggressive in pursuing agreements to run trials . . . it is very much the case that Mexico is leading the pack right now,” said Jonathan Terluk, deputy director of operations at Empra, a risk consultancy, who has been studying the vaccine race.

Ms Delgado said Mexico was not using the population as “guinea pigs” but acknowledged that a commitment to gain access to doses had been part of its discussions.

Pharmaceutical companies say future access to vaccines is never tied to a country’s willingness to host human trials. However, some groups said that participating in the development of a vaccine would be recognised in negotiations over future supplies.

“[J&J] believes that those countries and organizations that provide critical support for our vaccine research and development . . . should receive priority in consideration of the allocation of the vaccine given their enablement of global access,” the company said, in response to questions.

CureVac said it would “appropriately recognise the value and importance of the contribution of the clinical trial centres.”

The Russian Direct Investment Fund, the Kremlin’s state wealth fund that has financed the Gamaleya Institute’s Sputnik V vaccine, declined to comment on the Mexico trials but said approval by national healthcare regulators was “the main milestone” to start the supply of the vaccine.

ReiThera declined to comment. Sanofi, AstraZeneca and CanSino did not respond to a request for comment.

Brazil has also been a popular location for phase 3 trials and has agreed to test shots from AstraZeneca, SinoVac, J&J, CanSino and the partnership between Pfizer and BioNTech.

But Brazilian president, Jair Bolsonaro, who has often played down the risks of Covid-19, appeared recently to shift the country’s position on testing, rejecting the purchase by the health ministry of 46m doses of a shot from China’s SinoVac that was due to be trialled in São Paulo state.

“Any vaccine, before being made available to the population, must be scientifically proved by the ministry of health and certified by the national sanitary agency,” he said on Wednesday. “The Brazilian people will be guinea pigs of no one.”

Brazil and Mexico daily covid cases, 7-day average

Mexico and Brazil have been selected to test experiential vaccines in part because infection rates there have remained high. Using a seven-day average, Brazil has recorded more than 20,000 new cases a day since the start of June while Mexico has recorded more than 4,000 new cases a day since mid-June.

In addition, the large numbers of people in Mexico with underlying health conditions, such as diabetes, make it possible to test trial candidates on a range of different population type.

Mexico has already signed deals with Pfizer, AstraZeneca and CanSino for sufficient doses to inoculate 117m of its 127m people by the end of 2021, if those vaccines get approved. But phase 3 trials of other candidates will continue, the foreign minister has said, to also help to identify which shots are most effective for the Mexican population.

Additional reporting by Hannah Kuchler in New York, Donato Paolo Mancini and Anna Gross in London and Henry Foy in Moscow



Source link

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Emerging Markets

Ebay to sell South Korea unit for $3.1bn as local rivals target Coupang

Published

on

By


Ebay is set to sell its South Korea business to a local consortium for $3.1bn, according to people with knowledge of the matter, as rivals seek to turn up the heat on SoftBank-backed Coupang in the world’s fourth-largest ecommerce market.

The consortium, which consists of South Korea’s biggest bricks-and-mortar retailer E-Mart and internet group Naver, plans to buy an 80 per cent stake in eBay Korea for Won3.5tn ($3.1bn) with the US company retaining the remainder, said the people.

The purchase could help the consortium to overtake fast-growing Coupang, which raised $4.6bn in an initial public offering in New York in March to become the biggest player in South Korea’s highly competitive ecommerce market. Japanese technology group SoftBank is a large investor in Coupang.

Ebay Korea was the country’s third-largest ecommerce company with a 13 per cent market share last year, according to research group Euromonitor. Its three platforms — Gmarket, Auction and G9 — recorded Won20tn in transactions last year, data from Meritz Securities showed.

Euromonitor has forecast that South Korea’s ecommerce market will grow by 11 per cent this year to $116bn. But it is a fragmented market of more than a dozen players, with Coupang and Naver controlling 19 per cent and 14 per cent shares in terms of transaction volume, respectively.

South Korea is one of the world’s largest and fastest-growing ecommerce markets, driven by its tech-savvy population, high-speed internet infrastructure and densely populated environment. Ecommerce accounted for 35.8 per cent of the retail market last year, compared with 28.6 per cent in 2019, Euromonitor data showed.

E-Mart plans to fund the deal with Won3tn of asset-backed loans with the remainder paid by its cash holdings, while Naver will contribute Won100bn, according to an industry official close to the situation.

“Despite the funding structure, E-Mart needs Naver to make up for its weak online networks,” said the official.

Conglomerate Lotte Group and E-Mart were the final bidders for eBay Korea. Both have struggled to catch up with Coupang, which is investing heavily in logistics to boost its delivery times. Coupang almost doubled its revenues last year to $12bn as more consumers shifted to online shopping during the Covid-19 pandemic.

“Both Lotte and E-Mart were eager to take over eBay’s operations but E-Mart offered about Won500bn more,” added the industry official.

Naver is one of Korea’s most popular internet portals and more than 40 per cent of eBay Korea’s customers access it via the former’s search engine.

Shinsegae, E-Mart’s parent company, and Naver partnered in March by swapping stakes in each other worth Won250bn.

Ebay Korea declined to comment. E-Mart said in a regulatory filing that it was in talks with eBay but a sale had not been finalised. Naver said in a separate filing that the deal had not been concluded.



Source link

Continue Reading

Emerging Markets

ByteDance revenues more than doubled in 2020 to $34.3bn

Published

on

By


ByteDance increased its revenues 111 per cent last year to $34bn and had 1.9bn monthly users across its apps at the end of the year, said its incoming chief executive Liang Rubo on Thursday, according to people familiar with the matter.

The owner of the short-video apps TikTok and Douyin recorded a surge in users as coronavirus lockdowns across the world left people searching for more entertainment online. Douyin, the Chinese sister app to TikTok, was ByteDance’s largest driver of revenue and has become a destination for shoppers looking to buy products from livestreaming presenters.

Facebook, the world’s biggest social media group, reported 2.85bn monthly users as of March 31.

ByteDance recorded an annual gross profit of $19bn but a net loss of $45bn for the year because of non-cash items including share-based compensation and fair-value changes of its shares, and heavy investment in new businesses, the people said. The company had 110,000 employees at the end of they year.

The financials were first reported by the Wall Street Journal and Chinese media.

Its chief rival in China, Kuaishou, reported a net loss of $15.4bn on $8.5bn in revenue last year — four times less than ByteDance — and 481m monthly users during the period. Kuaishou is trading in Hong Kong at a market capitalisation of HK$801bn ($103bn), while ByteDance has yet to reveal its plans for an initial public offering.

ByteDance raised about $5bn in December at a $180bn valuation, according to people familiar with the matter. The Beijing-based company is the world’s most valuable start-up, according to CB Insights. 

Liang made his first all-hands staff meeting speech on Thursday after he began the transition to chief executive last month, following founder Zhang Yiming’s announcement that he would step down at the end of the year. Zhang said he wanted to focus on innovation and “longer-term initiatives”.

Liang, a ByteDance co-founder who staff regard as Zhang’s loyal right-hand man, was previously head of human resources. Even after a six-month handover period, staff said they expected him to not make big changes and to continue taking direction from Zhang.

As Beijing increases its scrutiny of tech giants, several high-profile founders and chiefs have stepped back this year. Colin Huang stepped down as chair of ecommerce platform Pinduoduo in March, days after Eric Jing resigned as chief of Ant Group.

Liang told employees he was disclosing the financial figures as part of a drive for greater transparency at the company.



Source link

Continue Reading

Emerging Markets

Coronavirus latest: Royal Caribbean delays inaugural sailing of ship due to Covid cases

Published

on

By


Monique Roffey in London with a poster of her novel ‘The Mermaid of Black Conch’
Monique Roffey in London with a poster of her novel ‘The Mermaid of Black Conch’, which is published in paperback this month by Vintage © Monique Roffey

In April 2020, as coronavirus spread around the world, Monique Roffey published her seventh book.

She went with UK-based Peepal Tree Press, a small Caribbean-focused independent company, to publish The Mermaid of Black Conch after the majors rejected her fantastical tale of a mermaid from another era.

“Indie published me in the eye of the storm,” Roffey says. “I did everything I could to get it noticed.”

The Trinidadian-born author crowdfunded £4,500 for a publicist for her novel but as the healthcare crisis took hold she feared her mermaid tale would slide by unnoticed.

She was struggling to pay the rent while the Covid-19 crisis cancelled book tours and festivals.

“Covid was potentially disastrous for my book,” she says. “It was in danger of falling into the Covid chasm.”

But then the lyrical tale of loneliness, love and otherness caught the attention of the literary world and judges applauded it. In January, the novel won the prestigious £30,000 Costa book award, with judges calling it “extraordinary”, “captivating” and “full of mythic energy and unforgettable characters”.

And, bingo, suddenly everyone wanted to read about the mermaid Aycayia, says Roffey, who (full disclosure) attended the same school in the outskirts of Port-of-Spain as I did. 

The story has sold about 60,000 copies in print and online and this month it is published in paperback format by Vintage. For two consecutive weeks this year the novel topped The Times bestseller list. Film rights could well be next.

“Against all the odds, I have done well during Covid,” Roffey says from her home in London. “In 20 years of writing, with many ups and downs, I have seen nothing quite like this.”

Her novel of fantasy and folklore tapped into a desire for reading and imagination during the dark days of coronavirus-induced lockdowns. Roffey joined many authors pivoting online with book launches and literary festivals, which meant she gained global readers.

“In 2020, the nation turned to books for comfort, escapism and relaxation,” says the Publishers Association, the UK’s trade organisation that serves book and journal publishers. “Reading triumphed, with adults and children alike reading more during lockdown than before.”

Income from fiction rose 16 per cent last year to £688m, while the total for consumer publications rose 7 per cent in the UK to £2.1bn, the UK trade body says. 

“Basically a book, which was roundly ignored, rejected, published in the first Covid wave and that nobody registered,” was relaunched, Roffey says.

From nobody wanting the book, suddenly billboards of its cover are cropping up around town, she adds.

This is the sixth article in a series for the blog that explores the effects of the pandemic on people and businesses around the world



Source link

Continue Reading

Trending